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Abstract
Bromelain is an aqueous extract from pineapple stem
that contains proteinases and exhibits pleiotropic
therapeutic effects, i.e., antiedematous, antiinflamma-
tory, antimetastatic, antithrombotic, and fibrinolytic
activities. In this study, we tested bromelain’s effects
on glioma cells to assess whether bromelain could be a
potential contributor to new antiinvasive strategies for
gliomas. Several complementary assays demonstrated
that bromelain significantly and reversibly reduced
glioma cell adhesion, migration, and invasion without
affecting cell viability, even after treatment periods
extending over several months. Immunohistochemistry
and immunoblotting experiments demonstrated that 3
and 1 integrin subunits and hyaluronan receptor CD44
protein levels were reduced within 24 hours of brome-
lain treatment. These effects were not reflected at the
RNA level because RNA profiling did not show any
significant effects on gene expression. Interestingly,
metabolic labelling with 35-S methionine demonstrated
that de novo protein synthesis was greatly attenuated by
bromelain, in a reversible manner. By using a trans-
activating signaling assay, we found that CRE-mediated
signaling processes were suppressed. These results
indicate that bromelain exerts its antiinvasive effects by
proteolysis, signaling cascades, and translational
attenuation. Neoplasia (2001) 3, 469–479.
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Introduction
Primary brain tumors (gliomas) arise and typically remain
within the central nervous system. They are characterized by
diffuse and extensive infiltration into the brain parenchyma,
rendering surgical removal and local radiotherapy ineffective.
The pattern of invasion appears to follow the path of blood
vessels and myelinated fiber tracts, and distant spread may
thus occur through the corpus callosum, resulting in bilateral
growth of the tumor [1 ]. Tumor cell invasion is defined as an
active translocation of neoplastic cells through the host
cellular and extracellular matrix (ECM) barriers [2 ], where
ECM may be defined as the naturally occurring extracellular
substrate upon and through which cells migrate, proliferate,
and differentiate, respectively [3 ]. The distribution of the
classical ECM proteins, such as laminin, collagen type IV,
fibronectin, and vitronectin, in the brain is limited to vascular
basement membranes and the glia limitans externa. During
tumor progression, the ECM and its cell surface receptors
may change. Changes in cell adhesion, proteolytic degrada-
tion of the ECM, and cell migration are common hallmarks of
tumor cell invasion. The dissemination of glioma cells is a
function of two cellular properties characterized by migration
and invasion. Although the two terms are used interchange-
ably in the context of tumor metastasis, there are functional
features that distinguish them. Classically, migration refers to
cell locomotion. In contrast, the process of invasion involves
migration, and the additional feature of a degradative
function, typically reflecting the tumor cells’ ability to trans-
locate through ECM barriers by the release of proteases [4].
Integrins represent a large class of at least 20 trans-
membrane heterodimer receptor proteins consisting of
various combinations of  and  subunits. Integrins mediate
cell–cell or cell–matrix adhesion, and it is thus not surprising
that gliomas utilize integrins for mobility along ECM compo-
nents. Interestingly, an upregulation of various integrins in
gliomas, compared to the normal brain, has been observed
[5]. The 31 integrin complex has been identified as one of
the main integrin receptors expressed on glioma cells [6 ].
This integrin complex binds to several ECM components
such as laminin, fibronectin, and collagen type IV. Studies
have demonstrated that blocking the 3 and 1 integrin
subunits with neutralizing antibodies inhibits glioma cell
migration and invasion [7–9].
Hyaluronic acid is a major component of the brain ECM. It
has been suggested that infiltration of glioma cells requires
interactions with hyaluronan receptors. Evidence for this has
been provided by Gunia et al. [10] and Breyer et al. [11 ], who
prevented glioma cell invasion by using specific monoclonal
antibodies against CD44 in different in vivo glioma models.
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Over the past two decades, bromelain, an extract from
pineapple stem (Ananas comosus ), has been used clinically
for a wide variety of maladies including edema, thrombo-
phlebitis, sinusitis, inflammation, rheumatic arthritis, and as
adjuvant cancer treatment [12]. Although poorly understood,
the pleiotropic effects of bromelain are considered to be due
to the complex mixture of closely related cysteine protei-
nases, proteinase inhibitors, phosphatases, glucosidases,
peroxidases, and other undefined compounds [13,14]. In
addition, bromelain has shown both antiproliferative and
antimetastatic effects in tumor models in vitro and in vivo
[15–19]. Despite this knowledge, no data exist on brome-
lain’s effects on glioma cells.
Because bromelain contains a mixture of proteinases,
we hypothesized that cleavage of integrins could prevent
their function as receptors and thereby also inhibit the
invasive capacity of the glioma cells. To test this
hypothesis, we analyzed the effects of a crude aqueous
bromelain extract on glioma cell adhesion, migration, and
invasion using several representative glioma cell lines in
various in vitro assays. We studied the effects of bromelain
on the expression of receptors known to be important in
glioma cell invasion, namely 31 integrin and the
hyaluronan receptor CD44 (HCAM). Finally, we assessed
the effects of bromelain treatment on gene expression and
cellular homeostasis. Our results show that bromelain can
reversibly inhibit glioma cell migration and invasion by
proteolytically affecting integrin expression. In addition,
bromelain effects are transduced into the intracellular
milieu of the cell to affect signaling cascades and protein
translation processes.
Materials and Methods
Bromelain
Crude bromelain extract called base powder from pine-
apple stem (A. comosus ) was purchased from CPC W.
Mu¨hlbauer, Hamburg, Germany. Its proteinase activity was
0.35 U/mg, using L-pyroglutamyl -L -phenylalanyl -L - leu-
cine-p -nitroanilide as substrate [20].
Cell Lines and Cell Cultures
The human glioma cell lines AN1/ lacZ, U-251/ lacZ, U-
251/GFP, A-172, and U-87/GFP were used in this study
[7,21,22]. The cells were cultured in complete growth
medium (CGM) consisting of: Dulbecco’s modified
essential medium (Sigma, St. Louis, MO) supplemented
with 10% heat- inactivated newborn calf serum, four
times the prescribed concentration of nonessential amino
acids, 2% glutamine, penicillin (100 IU/ml), and strepto-
mycin (100 g/ml). For the lacZ stable cell lines,
Geneticin (1 mg/ml, G-418; Sigma) was added to
maintain the lacZ -positive cells under selection pressure.
The cells were maintained in a standard tissue culture
incubator at 378C with 100% relative humidity, 95% air,
and 5% CO2. Multicellular spheroids were initiated by
seeding 5106 cells into 80 cm2 tissue culture flasks
base-coated with 0.75% agar in CGM [23]. The
spheroids were used between 5 and 7 days of culture.
Cell Adhesion Assay
Cell adhesion was evaluated according to Schulz et al.
[24]. Briefly, near-confluent monolayers were treated with
1 mM EDTA in phosphate-buffered saline (PBS), rinsed,
and suspended in CGM. The cells were seeded into 96-well
plates (3104 cells /well in 200 l ). After 30 and 60/80
minutes of incubation, under standard culture conditions, the
attached cells were fixed in 1% glutaraldehyde in PBS.
Fifteen minutes after fixation, the supernatant was aspirated
and 0.1% amido black (Merck, Darmstadt, Germany) in
sodium acetate buffer (pH 3.5) was added to the plate for
30minutes. The wells were rinsed with acidic water (acidified
with HCl to pH 3.5) and protein-bound dye was eluted with
50 mM NaOH. The optical densities of the wells were
recorded using a photometric microplate reader (Titertek
Multiscan Plus, Heidenreich, Oslo, Norway) at 595 nm
(maximum absorbance). The data, which were corrected for
background absorbance (CGM without cells ), were ana-
lyzed by one-way analysis of variance (ANOVA), and
Scheffe´’s test was used for post -hoc comparisons of mean
values.
Tumor Cell Migration
Cell migration was determined by seeding multicellular
spheroids (between 175 and 300 m in diameter ) individ-
ually into 96-well culture plates, and then the cell outgrowth
from the spheroids was evaluated [25,26]. Time lapse
studies were performed using a Leica DM IRBE inverted
microscope (Leica Lasertechnik GmbH, Heidelberg, Ger-
many) with an incubator (Edmund Bu¨hler GmbH & Co.,
Bodelshausen, Germany), which maintained a temperature
of 378C and an atmosphere of 95% O2 and 5% CO2.
Digitized images were obtained using a Photonic Science
analog camera, which was computer-controlled by Impro-
vision Open Lab 1.7.0 software ( Improvision, Image
Processing and Vision, Coventry, UK). This apparatus
enabled the automatic recording of pictures of the migrating
cells as a function of time. The images were obtained using
a 10 Hoffman objective. The assay was performed over
116 hours.
Invasion Assay
Tumor cell invasion was evaluated using an in vitro co-
culture model, where normal fetal rat brain cell aggregates
were confronted with multicellular tumor spheroids from
the green fluorescence protein (GFP)–transfected U-87
cell line. The procedure for producing brain cell aggre-
gates has been described in detail previously [27,28].
Briefly, the brain aggregates were prepared by mincing
brains from 18-day-old inbred BD-IX rat fetuses [29].
The brain tissue was serially trypsinized and the resulting
single cell suspension was allowed to reaggregate by
seeding 3106 cells into 16-mm multiwell plates, base-
coated with agar in CGM. The aggregates were trans-
ferred to an 80-cm2 tissue culture flask after 48 hours
470 Bromelain Inhibits Invasive Glioma Cells Tysnes et al.
Neoplasia . Vol. 3, No. 6, 2001
and cultured for 18 days prior to confrontation with tumor
spheroids.
U-87/GFP tumor spheroids (between 200 and 313 m
in diameter ) were transferred into 96-well plates base-
coated with agar in CGM. Single brain cell aggregates of
approximately the same size as the tumor spheroids were
added. The tumor spheroids and the brain cell aggregates
were placed in close contact with each other. The co-
cultures were incubated in CGM in the presence and
absence of 50 g/ml bromelain. The optimal bromelain
concentration was determined by dose–response experi-
ments, using the cell adhesion and migration assays. After
72 hours, the co-cultures were examined using a Leica
TCS NT confocal laser scanning microscope (Leica)
attached to an inverted (Leica DM IRBE) microscope.
Thirty - two optical sections were recorded over a distance
of 100 m into the co-cultures, with a resolution of
512512 pixels per channel. In order to improve the
quality of the slow scan mode, each section was recorded
as an average of four pictures. GFP was excited with the
488 nm line of an Ar–Kr laser and fluorescence was
obtained through a long pass filter (590 nm). The pinhole
setting was optimized to gain maximum confocal quality.
Visualization of the co-cultures was performed by the
fluorescence detector and the transmission detector,
which visualized the spheroids and the brain cell
aggregates, respectively. The serial image files were
transferred to a Silicon Graphics O2 workstation for
three-dimensional visualization, using AVS/Express
(Advanced Visual Systems, Waltham, MA) as described
elsewhere [30]. The invasion was quantified by analyzing
the 32nd section in each co-culture by the native Leica
software. Invasion was defined as the penetration of the
malignant green fluorescent cells into the brain cell
aggregates. Tumor cell invasion was quantified by
assessing the tissue area representing the original
spherical shape of the brain cell aggregate. Thereafter,
the area representing the remaining brain cell aggregate
was measured. The replacement of brain tissue by tumor
cells was calculated as the percent reduction of the brain
cell aggregate area [26]. The data were analyzed by
Mann-Whitney rank test.
Tumor Spheroid Growth
Spheroids (between 225 and 362 m in diameter ),
prepared from the AN1/ lacZ and U-87/GFP cell lines, were
cultured individually in 16-mm multiwell dishes base-coated
with agar in CGM in the presence and absence of 50 g/ml
bromelain. Two orthogonal diameters of the spheroids were
recorded over a 20-day period. The relative increase in
spheroid volume was calculated using the formula for the
volume of a sphere.
Immunohistochemistry
Tumor spheroids, prepared from the AN1/ lacZ glioma cell
line, were incubated for 4 days in 50 g/ml bromelain-
supplemented CGM or in CGM alone, rinsed in PBS,
embedded in Tissue-Tec (Miles, Elkhart, IN), and frozen
in thawing isopentane. Ten-micrometer sections were cut
using a Reichert cryomicrotome (Leica Instruments, Heidel-
berg, Germany) and transferred to poly-L- lysine–coated
slides. The specimens were fixed in acetone for 3 minutes
prior to incubation for 1 hour at 258C with a panel of
monoclonal antibodies (3 integrin subunit (1:50 dilution in
PBS) (Becton Dickinson, San Jose, CA), 1 integrin subunit
(1:100) (P4C10; Gibco BRL, Gaithersburg, MD), and CD44
(1:50) (Becton Dickinson). Following 35-minute wash
cycles in PBS, FITC-conjugated sheep anti-mouse IgG
(1:20) (Dako, Glostrup, Denmark) was added for 1 hour at
258C. Sections were then washed 35 minutes in PBS,
digested with RNAse (0.5 mg/ml), and nuclear-stained with
10 g/ml propidium iodide. The sections were examined
using a Leica TCS NT confocal laser scanning microscope
(Leica) attached to an upright (Leica DMRXA) microscope.
Protein Extracts
Protein extracts were prepared by scraping cells in 1 ml of
boiling extraction buffer [20 mM Tris, pH 8.0, 1 mM EDTA,
65 mM DTT, 0.3% sodium dodecyl sulfate (SDS)]. The
suspension was separated by centrifugation at 15,000g for
30 minutes at 48C. The supernatant was collected and
protein concentrations were determined by the Bio-Rad dye
binding assay (Bio-Rad Laboratories, Munich, Germany)
using bovine serum albumin as a standard. Twenty micro-
grams of protein extracts was heated at 958C for 5 minutes in
SDS sample buffer (0.125 M Tris /HCl, pH 6.8, 17.4% v/v
glycerol, 2% w/v SDS, 0.001% bromophenol blue, 2% v/v
 -mercaptoethanol ) and samples were separated by SDS
polyacrylamide gel electrophoresis (PAGE) using the
Criterion system (Bio-Rad).
Metabolic Labelling
Cells were cultured to 70% confluence in CGM prior to the
addition of 50 g/ml bromelain. Following up to 7 days of
bromelain treatment, cells were incubated in 1 mCi/ml 35-S
methionine in Dulbecco’s modified Eagle medium without
methionine (Gibco BRL). In some instances, bromelain-
treated cells were allowed to recover for up to 3 days in CGM
prior to radioactive methionine pulsing. After pulse labelling
for 30 minutes, cells were washed with CGM prior to extract
preparation. Proteins were fractionated by SDS-PAGE,
stained with Coomassie blue, dried, and exposed to film
until the desired signal - to-noise ratio was obtained.
Western Blotting
Fractioned proteins were transferred to nitrocellulose
membranes by electroblotting using the Criterion system
(Bio-Rad). Immunoblot analysis was performed in a
Western processor robot (Amersham, Buckinghamshire,
UK). Briefly, blots were placed in the processor and
treated with the following layers at 48C: 1) TBST (10 mM
Tris, pH 7.4, 154 mM NaCl, 0.5% Tween 20) and 5% dry
milk for 1 to 2 hours; 2) primary antibody diluted 1:1000;
integrin 3 ( I -19, sc-6592; Santa Cruz Biotechnology,
Santa Cruz, CA); integrin 1 (M-106, sc-8978; Santa
Cruz Biotechnology), HCAM (CD44) (H-300, sc-7946;
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Santa Cruz Biotechnology), in TBST for 4 to 8 hours; 3)
three 1-hour washes in TBST; 4) secondary antibody diluted
in TBST for 2 hours; and 5) three 1-hour washes in TBST.
The blots were then reacted with a chemiluminescence
reagent (Pierce Chemical, Rockford, IL) and exposed to
film until the desired signal - to-noise ratio was obtained.
Primary antibodies were detected by anti-rabbit, anti-goat,
or anti -mouse IgG (dilution 1/10,000; Amersham).
Figure 1. Bromelain inhibits glioma cell adhesion. The diagrams show adhesion of AN1 / lacZ (A ) and U-251 / lacZ (B ) human glioma cells exposed to increasing
concentrations of bromelain. The number of cells adhering to the plastic was quantified using photometry ( y - axis ). Data expressed as mean±SEM; n=8 in each
group. Asterisks indicate significant differences from control (ANOVA and Sheffe´’s test ). c=control ( complete growth medium ).
Figure 2. Bromelain inhibits glioma cell migration. (A ) Cell migration (48 hours ) from multicellular spheroids from different human glioma cell lines in 96 -wells with
and without bromelain ( 50 g /ml ). Bar, 100 m. (B ) Time lapse study of cells from an AN1 / lacZ spheroid, which had been allowed 48 hours of migration in DMEM
supplemented with 10% serum, before the medium was changed to a medium containing 50 g /ml bromelain. The time points refer to the time after bromelain was
added to the medium. *This picture was taken 96 hours after the bromelain medium was replaced with ordinary serum supplemented medium. Bar, 100 m.
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Gene Arrays
The expression of over 40 genes known to be important
for metastasis and apoptosis was profiled on membranes
from a GEArray Kit (SuperArray, Bethesda, MD). Briefly,
RNA was isolated (Trizol; Gibco BRL) from cells that had
been cultured either in CGM or treated with 50 g/ml
bromelain in CGM for 1 or 24 hours. Radioactive probes
were prepared using  -32-P dCTP and a RT-PCR protocol
and primers from the GEArray Kit (SuperArray). Membranes
containing DNA spots were hybridized at 688C in hybrid-
ization buffer containing radiolabeled DNA probes. Following
hybridization, membranes were washed extensively. The
most stringent wash was with 0.1 SSC (15 mM NaCl and
1.5 mM Na–citrate), 0.5% SDS at 688C. Membranes were
then wrapped in plastic and exposed in a Phosphorimager
(Fujifilm FLA-2000, Stockholm, Sweden) for a time course
to determine linear exposure times. Visual inspection was
used to analyze the results. Each membrane contained 21 or
23 genes that were spotted in duplicate. In addition, each
membrane contained multiple spots of the housekeeping
genes (actin and GAPDH) and a negative control (pUC18,
bacterial plasmid).
Transactivation Signaling Assay
Cells (AN1/ lacZ ) were seeded into 96-well plates (104
cells /well ). After 24 hours, the cells were transfected with
expression constructs containing promoter elements 50 to the
luciferase reporter gene. Three different promoter config-
urations were used: 1) a weak promoter and a cAMP
response element (CRE); 2) a weak promoter with an AP-1
cis -acting element; or 3) a weak promoter alone. These
constructs were obtained from Clontech (Clontech Mercury
signaling systems; Clontech Laboratories, Palo Alto, CA).
Fugene (Roche Molecular Biochemicals, Roche, Oslo,
Norway) was used according to the manufacturer’s instruc-
tions for cell transfection. Three days after the transfection,
cells were treated with 50 g/ml bromelain in CGM for 1 and
24 hours. Control cells were maintained in CGM. Extracts
were prepared using a luciferase reagent (Promega,
Madison, WI) and measured in a luminometer (Anthos Lucy
1; Anthos Labtec Instruments GmbH, Salzburg, Austria ).
Controls consisted of untransfected extract and yielded no
signal over the background. The data were entered into
Kaleidagraph (V3.5, Synergy) and box plots were gener-
ated.
Results
Bromelain Reversibly Disrupts Glioma Cell Adhesion and
Migration
We added bromelain to monolayer cultures of AN1/ lacZ
and U-251/ lacZ glioma cells and observed after 24 hours
that the cells were detached from the plastic surface and
Figure 3. Bromelain reduces glioma cell invasion into normal brain cell aggregates. Tumor cell invasion in 72 -hour co - cultures of spheroids prepared from the U -
87 /GFP human glioma cell line and normal fetal rat brain cell aggregates. Transmission light microscopy pictures of a control co - culture (A ) and a bromelain -
treated co - culture (B ). Scale bars, 100 m. t= tumor, b=brain. Three - dimensional reconstructions of confocal microscopy sections of the same tumor spheroids
combined with transmission pictures of the brain aggregate (C, control; D, bromelain - treated ). A linear color map ranging from zero ( dark blue, no transmission ) to
255 ( red, highest fluorescence intensity ) was used. The distance between the lines is 200 m along the x - and y - axes, and 27 m along the z -axis.
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floated in suspension as rounded and aggregated cells.
Dose–response experiments were performed to determine
the concentration of bromelain required to cause effects on
cell adhesion. There were small differences in the monolayer
cell adhesion to the plastic surface after 30 minutes of
incubation with the addition of different doses of bromelain.
But the addition of 25 to 100 g/ml bromelain to the medium
for 60 (U-251/ lacZ ) and 80 minutes (AN1/ lacZ ) caused a
significant decrease in optical density, and the cells started to
lose contact with the substrate (Figure 1 ). We chose
50 g/ml bromelain for use in further experiments. This
concentration of bromelain was comparable to those used in
other experimental systems [19].
In order to study glioma cell migration following bromelain
treatment, we generated spheroids and performed cell
migration assays in CGM (Figure 2A, upper panel ) and in
CGM containing bromelain ( lower panel ). Spheroids are
stable multicellular configurations that occur when cells are
grown in dishes, which have been base-coated with agar;
when placed in plastic tissue culture dishes with CGM, the
spheroids attach to the bottom of the dish and the cells
migrate outwards. All four cell lines tested (AN1/ lacZ, U-
251/ lacZ, U-251/GFP, A-172) showed a reduction in cell
migration after exposure to 50 g/ml bromelain (Figure 2A ).
Figure 4. Bromelain affects cell surface protein expression. Scanning confocal microscopy pictures of 3 and 1 integrin subunits and CD44 immunostained
spheroid sections (green signal ) from the AN1 / lacZ human glioma cell line. Nuclei are stained with propidium iodide ( red ). Upper panel: control spheroids; middle
panel: bromelain - treated spheroids. Scale bar, 100 m. Lower panel: corresponding Western blot of monolayer cultures; control cells marked with (  ) and
bromelain - treated cells marked with ( + ).
Figure 5. Transcriptional profiling following bromelain treatment. Gene
expression profiles of control (A ) and bromelain - treated ( 24 hours )
AN1 / lacZ human glioma cells (B ) in a cancer /metastasis GEArray. Probes
were prepared using RT -PCR techniques and hybridized to membrane
genes involved in tumor cell adhesion and genes for proteolysis of ECM
during tumor cell invasion. Following extensive washing, membranes were
exposed to a phosphoimager to capture an image. No large variations in
gene expression were detected following the bromelain treatment. The 3
integrin and CD44 are located, respectively, at 5C, 5D and 1E, 1F. The two
housekeeping genes actin and GAPDH are located, respectively, at 3G, 4G
and 5G, 6G, 7G, 8E, 8F, 8G, whereas the negative control ( pUC18,
bacterial plasmid ) is located at 1G, 2G. The signals were found to be within
the linear range of exposure.
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Treatment with heat - treated bromelain (1 hour at 708C) or
trypsin (50 g/ml) did not induce cell detachment in
monolayer cultures. We also observed that spheroids
prepared from different human glioblastoma biopsies were
unable to attach or migrate in bromelain-supplemented
medium, showing that the effects of bromelain were not
limited to glioma cell lines (data not shown).
Time lapse studies were performed to identify the
temporal characteristics of bromelain action. We observed
that in bromelain-supplemented media, the migrating cells
lost their adherence to the plastic surface and retracted,
during a 20-hour period, back to spheroids (Figure 2B ).
The spheroid lost contact with the bottom of the dish after 8
to 10 hours. Some single cells were observed, but most
were in the spheroid configuration. To demonstrate that this
was a reversible process, bromelain was removed and
replaced with fresh CGM. The spheroids then reattached to
the substrate and the cells started to migrate out again,
demonstrating that the cells were able to recover from the
bromelain treatment (Figure 2B* ).
Bromelain Treatment Reduces Tumor Cell Invasion
Because bromelain inhibited cell migration from multi-
cellular spheroids, we hypothesized that bromelain would
inhibit the tumors’ invasive properties as well. To examine
this possibility, we made co-cultures of brain cell aggre-
gates with U-87 glioma cells that had been stably
transfected with GFP. This model enabled us to evaluate
tumor cell invasion in living cultures by monitoring GFP
expression over the course of 3 days. Tumor cells
characteristically invaded the brain aggregates in the
untreated co-cultures (Figure 3A and C ). Less invasion
was observed following treatment with bromelain, along
with a more defined border between the tumor spheroid
and the brain aggregate (Figure 3B and D ). Quantification
of the results showed significant differences. In the control
group (n=4), there was a 68% reduction in the amount of
brain tissue after 3 days of co-culture, whereas in the
bromelain- treated group (n=4), there was only a 25%
reduction (P<0.02, Mann-Whitney statistical test for
unpaired nonparametric comparison).
Figure 6. Glioma spheroid growth and reversal of inhibited migration from spheroids. Cell growth of AN1 / lacZ (A ) and U-87 /GFP (B ) human glioma spheroids with
and without bromelain ( 50 g /ml ). The relative increase in volume is expressed as mean±SEM; control, n=4 (AN1 / lacZ ), n=5 (U -87 /GFP ); bromelain - treated
group, n=5. (C ) U -87 /GFP human glioma spheroid grown in bromelain - containing medium for 3 months. The spheroid is floating in the medium. (D ) Twenty - four
hours after bromelain removal. The spheroid is now attached to the culture dish and cells are migrating out from the spheroid.
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Cell Surface Protein Expression Is Affected by Bromelain
Treatment
We postulated that the reduced cell adhesion, migration,
and invasion were due, at least in part, to the proteolytic
effects of bromelain on the cell surface. To address this
assumption, we assayed for expression of 3 and 1 integrin
subunits; these represent two cell surface proteins that have
been implicated in glioma cell migration and invasion. In
addition, we assayed for another cell surface receptor
associated with invading glioma cells, CD44 (HCAM).
Immunohistochemical experiments, on control spheroids
from the AN1/ lacZ cell line, showed that all of these proteins
were expressed throughout the spheroid (Figure 4, upper
panel ). After 4 days of bromelain exposure, integrin and
CD44 expression was diminished and the expression of the
3 and 1 subunits was completely lost in the outermost
three to four cell layers of the spheroids (Figure 4, middle
panel ). We confirmed and extended these results by
performing Western blotting experiments on monolayers
that had been treated with bromelain for 2 and 24 hours.
Bromelain treatment for 2 hours did not alter 3 and 1
integrin and HCAM expression (data not shown). In contrast,
a decrease in 3 integrin, 1 integrin, and HCAM levels was
observed after 24 hours of bromelain treatment (Figure 4,
lower panel ). Immunoblots, using different glioma cell lines
and human glioblastoma biopsy extracts, also showed a
reduced expression of cell surface protein after bromelain
treatment (data not shown).
Transcriptional Profiling Is Unchanged Following Bromelain
Treatment
To identify if these effects on protein expression were
linked to a reduction in mRNA expression, we conducted
experiments using a gene array hybridization strategy. We
selected arrays that contained DNA encoding for genes
regulated during tumor metastasis and apoptosis pathways.
The 3 integrin and the CD44 genes were both included in
these 44 genes studied. Interestingly, no major changes
were observed in the gene expression profile following
bromelain treatment for 1 to 2 hours or 24 hours (Figure 5 ).
These results supported the notion that bromelain exerts its
effect through proteolytic cleavage.
Bromelain Treatment Does Not Influence Cell Survival
We subjected spheroids prepared from AN1/ lacZ and U-
87/GFP cells to bromelain treatment and analyzed the
spheroid volume for 20 days. Bromelain treatment had no
significant effect on spheroid growth for the two cell lines
studied (Figure 6A and B ). In addition, we did not observe
any increase in dead cells as determined by propidium iodide
staining, suggesting no cytotoxic effects resulting from
bromelain treatment. In a separate set of experiments, we
assessed cellular proliferation in bromelain- treated cells. We
cultured cells in bromelain for 3 days prior to addition of
tritium- labelled thymidine. Analysis for radioactive incorpo-
ration indicated that bromelain- treated cells incorporated the
radiolabeled thymidine, suggesting that bromelain- treated
cells continued to divide during and following bromelain
treatment (data not shown). Based on the results above, we
allowed spheroids to grow in bromelain for longer periods of
time, up to 3 months, prior to replacement with CGM. After
bromelain removal, cells once again attached and began to
migrate out of the spheroid (Figure 6C and D ).
Bromelain Attenuates De Novo Protein Synthesis
We treated cells with bromelain for 24 hours up to 7 days
and then pulsed them with 35-S methionine for 30 minutes.
Cellular extracts were prepared and proteins fractionated by
SDS-PAGE. This assay showed that following bromelain
treatment protein synthesis was decreased compared to
untreated cells (Figure 7 ). Interestingly, following 3 days of
recovery in CGM, we observed normal levels of protein
translation. This was our first indication that bromelain
treatment could affect intracellular mechanisms. There was
no indication that bromelain gained access to the intracellular
milieu because the GFP-expressing cells remained GFP-
positive (Figures 3C and D and 6C and D ).
Bromelain Alters Intracellular Signaling
Because protein synthesis was attenuated, we next
addressed if any signaling processes were interrupted
following bromelain treatment. Luciferase reporter con-
structs bearing cis -acting elements coupled to weak
promoters were transfected into equal numbers of cells
for 3 days. This was followed by bromelain treatment for
1 and 24 hours. The expression of luciferase was examined
Figure 7. Bromelain attenuates de novo protein synthesis in glioma cells.
SDS-PAGE showing newly synthesized proteins from 35 -S methionine -
labelled U -87 /GFP– transfected human glioma control cells ( Lane 1 ), cells
treated with bromelain for 7 days (Lane 2 ), and cells treated with bromelain for
4 days and then allowed a 3 -day recovery period in complete growth medium
(Lane 3 ). Molecular size markers are indicated to the right.
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in three different promoter paradigms: 1) a weak promoter
with a CRE element; 2) a weak promoter with an AP-1
element; and 3) a weak promoter. Phosphorylation of the
trans -acting factor (CREB or AP-1) was expected to
facilitate binding to the respective element and to activate
the promoter sequences to drive expression of the
luciferase enzyme. The data presented in the box plot
(Figure 8 ) were obtained following extract preparation and
processing for the luciferase assay. Several observations
were notable. Basal levels of both CRE- and AP-1–
mediated luciferase activity could be measured, and the
CRE element appeared to activate luciferase expression to
higher levels. CRE activation was significantly decreased,
following 1 hour of bromelain treatment, and this effect was
also observed at the 24-hour timepoint. It should be
emphasized that the level of CRE-activated luciferase was
reduced, but not totally blocked. In contrast, AP-1–
activated sequences were not significantly affected by
bromelain at any of the time points studied. Control
experiments were performed with transfected constructs
that contained only the weak promoter and the luciferase
gene, and luciferase activity was never detected over the
background levels.
Discussion
A fundamental management challenge presented by glioma
patients is to control the invasion of malignant cells into the
normal brain. The highly infiltrative behavior of gliomas
causes severe difficulties in achieving complete surgical
resections. To hinder the migration of the invasive glioma
cells without negative impact on neighboring bystander cells
represents an attractive treatment approach. In this study,
we have examined effects of the pineapple extract bromelain
on several glioma cell lines and glioblastoma biopsy
spheroids. Glioma cell lines with different characteristics
were chosen based on results from previous studies, assay
suitability (e.g., stably transfected with GFP ), and cell
availability. Our salient findings are: 1) bromelain treatment
of glioma cells reduces their ability to migrate and invade; 2)
cells undergoing treatment are viable and can divide; 3)
bromelain affects cell surface proteins, protein translation,
and intracellular signaling pathways; and 4) the effects of
bromelain are reversible.
Intrinsically, glioma cells are programmed to migrate and
invade brain tissue. All the glioma cells studied displayed
reduced adhesive, migratory, and invasive properties follow-
ing bromelain treatment. The cells were able to survive for
long periods of time in bromelain, there were no cellular signs
of destruction, and the effects were reversible, indicating the
potential also for neighboring non-cancer cells to recover.
Bromelain is thus a drug which, by local delivery to the tumor,
could localize the tumor and restrict glioma migration for
extended periods. These favorable antiinvasive drug attrib-
utes may provide a complementary treatment strategy in
combination with surgical removal. Bromelain was found to
affect cell surface receptor systems important for glioma cell
migration and invasion, namely the 3 and 1 integrin
subunits and CD44. Reduced expression of CD44 caused by
bromelain has also been shown by others on leukemia and
melanoma cells [19,31]. The reduction of cell surface
proteins is best explained by proteolysis because transcrip-
tional profiling revealed no obvious alterations. It is likely that
the mixture of proteases in bromelain cleavedmany, if not all,
cell surface markers. This assumption was supported by the
fact that molecules important for cell–cell adhesion, as well
as epidermal growth factor receptor expression, also were
decreased after bromelain treatment.
Of considerable interest is the observation that bromelain
inhibited protein translation. This is a novel finding that has
not been associated with bromelain treatment previously. It
is important to note that the translation machinery was
functional because we detected the expression of some
proteins. It is unknown how bromelain affects protein
translation. We have no evidence that bromelain has gained
intracellular access; if so, a reduced GFP expression in the
cell lines following bromelain treatment would have been
expected. If bromelain were present intracellularly, we
should also expect detrimental consequences to the cells
due to the proteolytic capacity of this compound. We
therefore favor the most simplistic model whereby bromelain
proteolytically cleaves the cell surface receptors resulting in,
among other phenomena, reduced cell migration. In addition,
the cleavage of transmembrane proteins can disrupt intra-
cellular signaling cascades and thereby disturb the transla-
tional machinery.
Figure 8. Bromelain affects nuclear signaling. AN1 / lacZ cells were trans-
fected with luciferase reporter constructs containing CRE or AP -1 cis - acting
elements prior to bromelain treatment for 0, 1, or 24 hours. Cells were
extracted and luciferase was measured. The data, shown in the form of a box
plot, indicate that CRE signaling was significantly affected following bromelain
treatment. The rectangle represents 50% of the data, and the mean is
indicated by the horizontal line dissecting the box. The lines above and below
the box establish the range of the data; a small open circle represents an
outlier. Numbers in the rectangle represent trial numbers. Trials were done in
duplicates. Asterisks denote significance [CRE 1 hour: P< .002; CRE 24
hours: P< .01, Kaleidagraph (V3.5, Synergy ) ].
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The specific signaling mechanisms affected by bromelain
are unknown, but integrins are, in addition to promoting cell
adhesion and migration, known to contribute to intracellular
signaling processes [32]. Integrins are considered to
influence several pathways by regulating the activity of
transcription factors [33,34]. Downstream effects of brome-
lain have been reported by Mynott et al. [35], who found that
bromelain inhibited ERK-2 phosphorylation and signaling in
T cells. The ERKs belong to the family of mitogen-activated
kinases (MAPK), which act as a key element in the signaling
pathways involved in transducing receptor - initiated signals
to the nucleus [36,37]. There is also some evidence that
links integrin engagement together with the activation of the
MAPK pathway [38]. Cell adhesion to the ECM has also
been suggested to induce a rapid increase in the translation
of preexisting messenger RNA [39,40] and translational
control at the site of integrin binding [41]. Bromelain, by its
effect on integrins, may interfere with such mechanisms. The
inhibition of cell adhesion by bromelain may also result in an
inability of the cells to transmit the signals normally
generated by attached cells to the nucleus, thus resulting
in reduced protein synthesis. The CRE-mediated luciferase
activity was significantly reduced after bromelain treatment.
Whether a bromelain-mediated relationship exists between
CRE signaling and protein translation is unknown. We
suggest that the decrease in CRE-mediated activation was
not due to a general decrease in intracellular signaling
because bromelain did not affect AP-1–mediated luciferase
activity. To address these issues will require further studies,
but the results indicate that intracellular pathways are
differentially affected during bromelain treatment.
Our results suggest that the antiinvasive property of
bromelain is dependent on its proteolytic activity. However,
in 1988, Batkin et al. [16] showed that heat inactivation of
bromelain did not abolish its antimetastatic capacity in the
Lewis lung tumor model on C57B1/6 mice. Grabowska [42]
found, by evaluating tumor cell invasion through an ECM
layer in vitro, that heat inactivation of bromelain did not
reduce its antiinvasive capacity on mammary tumor and
melanoma cells. These observations, in contrast to the here
reported findings, may only be settled when the responsible
components of the crude bromelain extract have been
isolated and characterized by biochemical and pharmaco-
logical criteria, the latter by means of animal experiments.
Bromelain consists of a mixed group of proteins with
different fractions and activities. Future challenges will be to
isolate and characterize, using biochemical methods, the
component(s) of bromelain responsible for the various
effects observed at the cellular level, and to put these
findings into the complex context of invading glioma cells
both in vitro and in vivo. The striking effects of bromelain on
glioma cell adhesion, migration, and invasion in vitro provide
valuable insight for further work with this compound.
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